-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JpzBR3CT3pivqKR0YdkgLjMCChXXW2M3+opjeMx/G33N03RbK9t4afGMqaYaBZaw DbpuIH4HJ9pm+FqxEhLZUg== 9999999995-10-000461.txt : 20100210 9999999995-10-000461.hdr.sgml : 20100210 20100210001512 ACCESSION NUMBER: 9999999995-10-000461 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100209 DATE AS OF CHANGE: 20100210 EFFECTIVENESS DATE: 20100209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENEREX BIOTECHNOLOGY CORP CENTRAL INDEX KEY: 0001059784 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 820490211 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-164591 FILM NUMBER: 10586110 BUSINESS ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CANADA STATE: A1 ZIP: M5J 2G2 BUSINESS PHONE: 4163642551 MAIL ADDRESS: STREET 1: 33 HARBOUR SQ STREET 2: STE 202 CITY: TORONTO ONTARIO CA STATE: A1 ZIP: M5J 2G2 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2010-02-09 09:00:00
S-3
0001059784 GENEREX BIOTECHNOLOGY CORP 333-164591
-----END PRIVACY-ENHANCED MESSAGE-----